Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] CURRENT ASSETS Cash and Cash Equivalents, at Carrying Value Cash and money market funds, Amortized Cost Cash and cash equivalents Debt Securities, Available-for-Sale, Current Marketable securities Short-term marketable securities Grants Receivable, Current Receivables Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current TOTAL CURRENT ASSETS Property, Plant and Equipment, Net Property and equipment, net PROPERTY AND EQUIPMENT, net Other Assets [Abstract] OTHER ASSETS Operating Lease, Right-of-Use Asset Lease right-of-use assets, net Other Assets Other assets Assets TOTAL ASSETS Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] CURRENT LIABILITIES Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total accrued expenses Operating Lease, Liability, Current Lease liabilities, current Current portion of lease liabilities Government Assistance, Liability, Current CIRM liability, current Total repayment amount Contract with Customer, Liability, Current Deferred revenue, current Liabilities, Current TOTAL CURRENT LIABILITIES Liabilities, Noncurrent [Abstract] LONG-TERM LIABILITIES Operating Lease, Liability, Noncurrent Lease liabilities, net of current Lease liabilities, net of current Liabilities, Noncurrent TOTAL LONG-TERM LIABILITIES Liabilities TOTAL LIABILITIES Commitments and Contingencies. COMMITMENTS AND CONTINGENCIES (NOTE 15) Stockholders' Equity Attributable to Parent [Abstract] STOCKHOLDERS' EQUITY Preferred Stock, Value, Issued Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding Common Stock, Value, Issued Common stock, $0.001 par value, 100,000,000 shares authorized, 57,664,673 and 57,370,909 shares issued and outstanding, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Balance Balance TOTAL STOCKHOLDERS' EQUITY Liabilities and Equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common Stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Revenues [Abstract] REVENUE Revenue from Contract with Customer, Including Assessed Tax Revenue Revenues Total revenue TOTAL REVENUE Operating Expenses [Abstract] OPERATING EXPENSES Research and Development Expense Research and development Total research and development expense General and Administrative Expense General and administrative Total general and administrative expense Operating Expenses TOTAL OPERATING EXPENSES Operating Income (Loss) LOSS FROM OPERATIONS Nonoperating Income (Expense) [Abstract] OTHER INCOME (EXPENSE) Other Income Other income Investment Income, Interest and Dividend Investment income Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Loss on disposal of fixed assets Nonoperating Income (Expense) Total non-operating income, net TOTAL OTHER INCOME (EXPENSE) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes LOSS BEFORE INCOME TAXES Income Tax Expense (Benefit) (Provision for) benefit from income taxes NET LOSS Net loss Other Comprehensive Income (Loss), Net of Tax [Abstract] OTHER COMPREHENSIVE INCOME (LOSS) Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Net unrealized gain (loss) on marketable securities Unrealized gain (loss) on marketable securities Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss COMPREHENSIVE LOSS Earnings Per Share, Basic Net loss per share, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average number of shares, diluted (in shares) CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statement [Table] Equity Components [Axis] Equity Component [Domain] COMMON STOCK [Member] COMMON STOCK ADDITIONAL PAID-IN CAPITAL [Member] ADDITIONAL PAID-IN CAPITAL OTHER COMPREHENSIVE INCOME [Member] OTHER COMPREHENSIVE INCOME ACCUMULATED DEFICIT [Member] ACCUMULATED DEFICIT Statement [Line Items] Statement Shares, Outstanding Balance (in shares) Balance (in shares) Stock Issued During Period, Shares, New Issues Number of common stock shares issued Issuance of common stock, net of fees (in shares) Value of stock issued as a result of the exercise of warrants. Stock Issued During Period, Value, Warrants Exercised Exercise of common warrants Number of warrants exercised during the current period. Stock Issued During Period, Shares, Warrants Exercised Exercise of common warrants (in shares) Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock-based compensation Stock Issued During Period, Value, Restricted Stock Award, Gross Vesting of restricted stock awards Stock Issued During Period, Shares, Restricted Stock Award, Gross Vesting of restricted stock awards (in shares) Stock Issued During Period, Value, Stock Options Exercised Stock options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised Stock options exercised (in shares) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Stock or Unit Option Plan Expense Stock-based compensation Restricted Stock or Unit Expense Restricted stock awards granted Amount of noncash expense included in interest expense to amortize or accretion of debt discount and premium associated with the related debt instruments. Amortization Or Accretion Of Debt Discount (Premium) Amortization/accretion of note premiums/discounts The expense charged against earnings related to noncash lease , which is added back to net income when calculating cash provided by (used in) operations using the indirect method. Noncash Lease Expenses Changes in lease liabilities Other Noncash Income (Expense) Other Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: The increase (decrease) during the reporting period in grants receivable (or one business cycle). Increase Decrease from Grants Receivable Receivables Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Marketable Securities Purchase of marketable securities Proceeds from Sale and Maturity of Marketable Securities Proceeds from sales and maturities of marketable securities Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment The cash outflow for acquisition of leasehold improvements during the period. Payments to Acquire Leasehold Improvements Payments for leasehold improvements The cash outflow relating to construction in progress. Payments For Construction In Progress Payments for construction in progress Net Cash Provided by (Used in) Investing Activities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Proceeds from Stock Options Exercised Proceeds from exercise of stock options Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents balance at end of period Cash and cash equivalents balance at beginning of period ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS No definition available. CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES Cash, Cash Equivalent, and Marketable Security [Text Block] CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES NA RECEIVABLES AND OTHER CURRENT ASSETS The entire disclosure for current receivables and other current assets. Current Receivables And Other Current Assets [Text Block] RECEIVABLES AND OTHER CURRENT ASSETS PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] PROPERTY AND EQUIPMENT LEASES Lessee, Operating Leases [Text Block] LEASES COLLABORATIONS, LICENSES AND REVENUE Revenue from Contract with Customer [Text Block] COLLABORATIONS, LICENSES AND REVENUE RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS GOVERNMENT GRANTS AND OTHER INCOME The entire disclosure about government grant awards. Government Grant Awards Disclosure [Text Block] GOVERNMENT GRANTS AND OTHER INCOME ACCRUED EXPENSES AND CLINICAL TRIAL ACCRUALS Disclosure of accounting policy for recognizing and measuring accrued liabilities, current. Accrued Liabilities [Policy Text Block] ACCRUED EXPENSES AND CLINICAL TRIAL ACCRUALS STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] STOCK-BASED COMPENSATION STOCKHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME INCOME TAXES Income Tax Disclosure [Text Block] INCOME TAXES RECENT ACCOUNTING PRONOUNCEMENTS Accounting Standards Update and Change in Accounting Principle [Text Block] RECENT ACCOUNTING PRONOUNCEMENTS COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Business Description and Accounting Policies [Text Block] Description of Business Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Consolidation, Policy [Policy Text Block] Basis of Consolidation Reclassification, Comparability Adjustment [Policy Text Block] Reclassification Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Risk Marketable Securities, Policy [Policy Text Block] Marketable Securities Disclosure of accounting policy for cloud computing arrangements. Cloud Computing Arrangements, Policy [Policy Text Block] Cloud Computing Arrangements ("CCA") Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Long-Lived Assets Lessee, Leases [Policy Text Block] Leases Revenue Recognition, Policy [Policy Text Block] Revenue Recognition Receivable [Policy Text Block] Accounts Receivable Research and Development Expense, Policy [Policy Text Block] Research and Development Compensation Related Costs, Policy [Policy Text Block] Stock-Based Compensation Income Tax, Policy [Policy Text Block] Income Taxes Earnings Per Share, Policy [Policy Text Block] Basic and Diluted Loss per Share New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of fair value measurements by level Debt Securities, Available-for-Sale [Table Text Block] Summary of cash, cash equivalents and marketable securities Property, Plant and Equipment [Table Text Block] Schedule of property and equipment, net Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of maturities of lease liabilities and the reconciliation of lease liabilities Lease, Cost [Table Text Block] Schedule of operating lease cost Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Class of Warrant or Right [Table] Option Indexed to Issuer's Equity [Axis] Option Indexed to Issuer's Equity, Type [Domain] Stock Option Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Warrant [Member] Warrant Class of Warrant or Right [Line Items] STOCK-BASED COMPENSATION Tabular disclosure of all warrant activity during the period. Schedule Of Warrant Activity [Table Text Block] Schedule of warrant activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of fair value of option using Black-Scholes option Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed. Schedule Of Employee And Nonemployee Service Share-Based Compensation Allocation Of Recognized Period Costs Table Text Block Schedule of employee and non-employee stock based compensation expense Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of employee and non-employee stock option Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] Summary of the activity of restricted stock awards Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Summary of changes in accumulated other comprehensive loss Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Summary of operating segment expenses Accounting Policies [Table] Range [Axis] Range [Domain] Minimum Minimum Maximum Maximum Accounting Policies [Line Items] ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Property, Plant and Equipment, Useful Life Estimated useful lives (in years) Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Level 1 Level I Level 2 Level II Financial Instrument [Axis] Financial Instruments [Domain] Money Market Funds [Member] Money market funds US Treasury Securities [Member] U.S treasury securities U.S. treasuries US Government Agencies Debt Securities [Member] U.S. government agencies Corporate Bond Securities [Member] Corporate bonds Commercial Paper [Member] Commercial papers Measurement Frequency [Axis] Measurement Frequency [Domain] Recurring Recurring Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] FAIR VALUE MEASUREMENTS Cash and Cash Equivalents, Fair Value Disclosure Cash and money market funds, Fair Value Cash equivalents Assets, Fair Value Disclosure Total financial assets Debt Securities, Available-for-Sale [Table] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Represents information pertaining to cash and money market fund. Cash And Money Market Funds [Member] Cash and money market funds Debt Securities, Available-for-Sale [Line Items] CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized Losses Debt Securities, Available-for-Sale Fair Value Amortized cost of cash and cash equivalents and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Cash, Cash Equivalents And Available-for-sale Debt Securities, Amortized Cost Total cash, cash equivalents and marketable securities, Amortized Cost Amount of unrealized gain on cash and cash equivalents and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Cash, Cash Equivalents And Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Before Tax Total cash, cash equivalents and marketable securities, Unrealized Gains Amount of unrealized loss on cash and cash equivalents and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Cash, Cash Equivalents And Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Before Tax Total cash, cash equivalents and marketable securities, Unrealized Losses Amount of cash and cash equivalents and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Cash, Cash Equivalents And Available-for-sale Debt Securities, Fair Value Total cash, cash equivalents and marketable securities, Fair Value The amount of receivables under Employee Retention Credit, CARES Act. Employee Retention Credit, CARES Act, Receivable Receivables under "ERC" Useful life of hosting arrangement that is service contract., in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Hosting Arrangement, Service Contract, Useful Life Useful life of hosting arrangement Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization Total capitalized implementation costs Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, Accumulated Amortization Cost of accumulated amortization from hosting arrangement Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization Amortization expense Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Furniture and fixtures [Member] Furniture and fixtures Laboratory equipment [Member] Laboratory equipment Computer Equipment [Member] IT equipment Manufacturing Facility [Member] Manufacturing equipment Leasehold improvements [Member] Leasehold improvements Construction in Progress [Member] Construction in progress Property, Plant and Equipment [Line Items] PROPERTY AND EQUIPMENT Property, Plant and Equipment, Gross Property and equipment, gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less accumulated depreciation Depreciation Depreciation Impairment, Long-Lived Asset, Held-for-Use Long-lived assets impairment Lessee, Lease, Description [Table] Name of Property [Axis] Name of Property [Domain] Represents the information pertaining to Property Located at 10865 Road to Cure in Diego. Property Located at 10865 Road to Cure in Diego Property Located at 10865 Road to Cure in Diego Lease Contractual Term [Axis] Lease Arrangement, Type [Domain] Represents information pertaining to facilities lease. Facilities Lease Lessee, Lease, Description [Line Items] LEASES Net Rentable Area Area under lease Lessor, Operating Lease, Term of Contract Initial lease term The percent of escalation of annual base rent of lessee's operating lease. Lessee, Operating Lease, Annual Rent Escalation, Percent Annual rent escalation, percentage Lessee, Operating Lease, Renewal Term Lease renewal term Increase (Decrease) in Operating Lease Liability Increase in operating lease liabilities Amount of increase (decrease) in operating lease right-of-use asset. Increase (Decrease) In Operating Lease, Right Of Use Asset Increase in right-of-use assets Represents the tenant improvement allowance receivable from the landlord. This allowance is treated as a lease incentive under ASC 842 and results in remeasurement of the lease liability and rightofuse asset. Tenant Improvement Allowance Receivable Tenant improvement allowance receivable in 2026 The amount of base lease rent per month under the operating lease. Lessee Operating Lease, Base Lease Rent Per Month Base rent per month Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2026 (remainder) Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Lessee, Operating Lease, Liability, to be Paid, after Year Four Thereafter Operating Leases, Future Minimum Payments Due Total minimum lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Operating Lease, Liability Total operating lease liabilities Total operating lease liabilities Operating Lease, Liability [Abstract] Included in the consolidated balance sheet: Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate Operating Lease, Cost Operating lease costs Variable Lease, Cost Variable lease costs Operating Lease, Payments Lease payments Represents the information pertaining to corporate offices under operating lease. Corporate Offices Lease [Member] Short-term offices lease Operating Leases, Rent Expense, Net Short-term operating lease cost LICENSE AGREEMENTS [Table] Scenario [Axis] Scenario, Unspecified [Domain] Until the date of expiration of the last to expire patent within the parent rights. Patent rights Patent rights Non-payment of royalties. Non Payment of Royalties Non Payment of Royalties Information pertaining to failure to undertake commercially reasonable efforts to exploit the patent rights or future patent rights CSMC Agreement Compliance CSMC Agreement Compliance Material breach has not been cured. Material Breach Has Not Been Cured Material Breach Has Not Been Cured Fails to cure that breach after notice from CSMC. Fails To Cure Breach after Notice From CSMC Fails To Cure Breach after Notice From CSMC Milestone Payments in Phases [Axis] Milestone Payments in Phases [Domain] Obtention of FDA Approval Related Party Transaction [Axis] Related Party Transaction [Domain] Represents information pertaining to Rome license agreement. Rome License Agreement Rome License Agreement JHU License Agreement JHU License Agreement No definition available. CSMC License Agreement CSMC License Agreement Exosomes License Agreement Exosomes License Agreement Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent event Subsequent events Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Represents information pertaining to Commercialization and Distribution Agreement with Nippon Shinyaku, Co., Ltd., United States. Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States Represents information pertaining to Commercialization and Distribution Agreement with Nippon Shinyaku, Co., Ltd., Japan. Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, Japan Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, Japan Represents information pertaining to Exclusive Commercialization and Distribution Agreement with Nippon Shinyaku, Co., Ltd. Japan Distribution Agreement NA LICENSE AGREEMENTS [Line Items] COLLABORATIONS, LICENSES AND REVENUE The amount paid for royalties on an annual basis. Annual Payments For Royalties Minimum annual royalty payments Amount of milestone payments payable under the JHU License Agreement. Potential Milestone Payments Potential milestone payments The amount of milestone payments accrued and not paid during the period. Milestone Payments Accrued Milestone payments accrued Milestone payments to be made upon successful completion of certain phases as per License agreement. Milestone Payments To Be Made Upon Successful Completion Of Certain Phases Milestone payments to be made upon completion of certain phases Period for which agreement will be effective. Period of Agreement Will be in Effective Agreement effective period Threshold period to cure breach. Threshold Period to Cure Breach Threshold period to cure breach These lines are represents that notice period. Written Notice Period Notice period Represents the agreement termination period. Agreement Termination Period Agreement termination period Upfront Payment made during the period Upfront Payment Upfront payment Contract with Customer, Liability Deferred revenue liability Revenue, Remaining Performance Obligation, Amount Upfront for performance obligation Accounts Receivable, after Allowance for Credit Loss Accounts receivable Schedule of Related Party Transactions, by Related Party [Table] Related Party [Axis] Related Party [Domain] Board of Directors Chairman [Member] Board of Directors Chairman Investor [Member] Investor Consulting Agreement with Frank Litvack Consulting Agreement with Frank Litvack Information pertaining to agreements for consulting and advisory services. Consulting Agreement [Member] Consulting Agreement Counterparty Name [Axis] Counterparty Name [Domain] Represents the member information pertaining to Nippon Shinyaku Co., Ltd. ("Nippon Shinyaku"). Nippon Shinyaku Co., Ltd. [Member] Nippon Shinyaku Nippon Shinyaku Co., Ltd Related Party Transaction [Line Items] RELATED PARTY TRANSACTIONS Monthly consulting fees as per consulting agreement entered into with related party. Monthly Consulting Fees to Related Party Monthly consulting fees Terminable notice period. Terminable Notice Period Notice period for termination of agreement Annual consulting fees as per consulting agreement entered into with related party. Annual Consulting Fees To Related Party Annual consulting fees Due to Related Parties, Current Accounts payable and accrued expenses, related party The number of agreements entered into. Number Of Agreements Entered Number of agreements The percentage of common stock of the reporting entity owned by a third-party. Entity Common Stock, Ownership Percentage Entity common stock, ownership percentage Other Liabilities Outstanding payables Government Assistance [Table] Grantor [Axis] Grantor [Domain] California Institute for Regenerative Medicine Represents information pertaining to government assistance amount repayable within three calendar days following execution of the agreement. Repayable Within Three Calendar Days Following Agreement Execution [Member] Repayable within three calendar days following agreement execution Represents information pertaining to government assistance amount repayable within June 12, 2026. Repayable Within June 12, 2026 [Member] Repayable within June 12, 2026 Debt Instrument [Axis] Debt Instrument, Name [Domain] Represents information relating to the California Institute For Regenerative Medicine Loan ("CIRM Loan"). California Institute For Regenerative Medicine Loan [Member] California Institute For Regenerative Medicine Loan Government Assistance [Line Items] GOVERNMENT GRANTS AND OTHER INCOME Grant Award Liability CIRM liability The number of tranches relating to repayment of government assistance amount. Government Assistance, Liability, Number Of Tranches Number of tranches Amount of government assistance that the entity is obligated to repay as of the reporting date under the terms of the assistance arrangement or related repayment agreement. Government Assistance Amount, Repayable Amount of principal relating to government assistance. Government Assistance, Liability, Principal Amount Government assistance, liability, principal amount Amount of accrued interest relating to government assistance. Government Assistance, Liability, Accrued Interest Government assistance, liability, accrued interest Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable related to clinical expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Clinical Expenses Accrued clinical expenses Employee-related Liabilities, Current Accrued payroll and related costs Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction work in progress costs. Accrued Liabilities, Construction In Progress Cost, Current Accrued construction in progress costs Other Accrued Liabilities, Current Other accrued expenses Class of Warrant or Right, Outstanding Warrants Outstanding at Ending Warrants Outstanding at Beginning Number of warrants or rights granted during the period. Class Of Warrant Or Right Granted Warrants Granted Number of warrants or rights Exercised during the period. Class Of Warrant Or Right Exercised Warrants Exercised Weighted average exercise price per share or per unit of warrants or rights outstanding. Class Of Warrant Or Right Weighted Average Exercise Price Weighted Average Exercise Price Outstanding at Ending Weighted Average Exercise Price Outstanding at Beginning Exercise price per share or per unit of warrants or rights granted. Weighted Average Exercise Price Granted Weighted Average Exercise Price Granted Exercise price per share or per unit of warrants or rights exercised. Class Of Warrant Or Right Exercised Weighted Average Exercise Price Weighted Average Exercise Price Exercised Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] STOCK-BASED COMPENSATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, Maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rates, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rates, Maximum Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Domain] General and administrative General and administrative Research and development Research and development Represents information pertaining to time based stock options. Time Based Stock Options [Member] Non-vested stock options Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] STOCK-BASED COMPENSATION Allocated Share-based Compensation Expense Stock-based compensation cost Stock-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at the end of the period Outstanding at the beginning of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Expired/Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable at March 31, 2026 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at end of the period Outstanding at beginning of the period Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired/Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at March 31, 2026 Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Outstanding at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Exercisable at March 31, 2026 Disclosure Stockholders Equity, stock Options And Warrants Additional Information [Table] Restricted Stock Units (RSUs) [Member] Restricted Stock Units Disclosure Stockholders Equity, stock Options And Warrants Additional Information [Line Items] STOCK AWARDS, WARRANTS AND OPTIONS Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of shares received in exchange, per share vested Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Outstanding, ending Outstanding, beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Expired/Cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average grant date fair value, ending Weighted average grant date fair value, beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value, vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted average grant date fair value, expired/cancelled Option Indexed to Issuer's Equity, Type [Axis] Plan Name [Axis] Plan Name [Domain] n/a Stock Option Plan 2021 Stock Option Plan 2021 Represents information pertaining to 2025 Equity Incentive Plan. Equity Incentive Plan 2025 [Member] Stock Option Plan 2025 Represents information pertaining to performance-based stock options. Performance Based Stock Options [Member] Performance-based options Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares authorized for issuance The percentage of annual increase for each year to authorized shares under any stock compensation plan. Share-Based Compensation Arrangement By Share-Based Payment Award Percentage Of Annual Increase In Number Of Shares Authorized Percentage of outstanding shares Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Number of additional shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Number of shares available for issuance Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Terms of stock option plans Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Estimated weighted fair value of option granted (in per share) Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Total unrecognized fair value compensation cost Period during which the performance conditions has to be satisified, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Share-Based Compensation Arrangement by Share-Based Payment Award, Performance Period Performance period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period NA Stockholders’ Equity and Accumulated Other Comprehensive Income [Table] Sale of Stock [Axis] Sale of Stock [Domain] Represents the information pertaining to December 2025 underwriting agreement. December 2025 Underwritten Public Offering [Member] December 2025 Underwritten Public Offering Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Stockholders’ equity and accumulated other comprehensive incomes [Line items] STOCKHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME The number of shares issued or sold upon exercise of underwriter's option. Number of Shares Issued in Over-Allotment Transaction Number of shares issued or sold upon exercise of underwriter's option. Shares Issued, Price Per Share Public offering price Proceeds from Issuance of Common Stock Gross proceeds from sale of common stock Payments of Stock Issuance Costs Reimbursement of expenses Represents information pertaining to September 2025 ATM program. September 2025 ATM Program [Member] September 2025 ATM Program The maximum value of share authorized. Common Stock, Shares Authorized, Value Maximum aggregate offering price Percentage of commission on sale price per common shares sold to be paid by the entity. Commission Rate On Sale Price Per Share Commission rate on sale price per share AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income/(Loss) AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Net Unrealized Gains/(Losses) Available-For-Sale Securities Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restructuring Reserve Restructuring reserve Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single Reportable Segment [Member] Single reportable segment Represents information pertaining to research and development compensation and benefits expense. Research And Development Compensation And Benefits Expense [Member] Compensation and benefits Represents information pertaining to research and development duchenne muscular dystrophy program (Deramiocel). Research And Development Duchenne Muscular Dystrophy Program [Member] Duchenne muscular dystrophy program (Deramiocel) Represents information pertaining to research and development exosomes platform research. Research And Development Exosomes Platform Research [Member] Exosomes platform research Represents information pertaining to other research and development (R&D) segments expenses. Research And Development Other Expense [Member] Other R&D segment expenses Segment Reporting Information [Line Items] SEGMENT INFORMATION Number of Operating Segments Number of operating segment Number of Reportable Segments Number of reportable segment Research and Development Expense [Abstract] Research and development expense: Amount, excluding non-cash expenses, of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and write-off of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Research and Development Expense, Excluding Noncash Expense Total research and development expense, excluding non-cash expense Amount of stock based compensation expense pursuant to research and development expenses. Research and Development Expense, Share Based Compensation Expense Stock-based compensation expense Amount of depreciation and amortization expense pursuant to research and development expenses. Research and Development Expense, Depreciation And Amortization Depreciation and amortization General and Administrative Expense [Abstract] General and administrative expense: Labor and Related Expense Compensation and benefits Other General and Administrative Expense Other G&A segment expenses The aggregate total, excluding non-cash expenses, of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. General and Administrative Expense, Excluding Noncash Expense Total general and administrative expense, excluding non-cash expense Amount of stock based compensation expense pursuant to general and administrative expense. General and Administrative Expense, Share Based Compensation Expense Stock-based compensation expense Amount of depreciation and amortization expense pursuant to general and administrative expense. General and Administrative Expense, Depreciation And Amortization Depreciation and amortization Other Nonoperating Income (Expense) Other income (expense) This member represents the board of director. Karimah Es Sabar [Member] Karimah Es Sabar